Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.
Lancet Reg Health Eur
; 32: 100681, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37671127
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Lancet Reg Health Eur
Year:
2023
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom